SDS Clinical Trials, Inc.

Santa Ana, California CA 92705

2 studies enrolling now · 24 studies all time

What they study most

Attention Deficit/Hyperactivity Disorder, Cataplexy, Excessive Daytime Sleepiness, Idiopathic Hypersomnia, Impaired Cognitive Function, Insomnia, Narcolepsy, Narcolepsy Type 1, Narcolepsy Type 1 (NT 1), Narcolepsy Type 1 (NT1), Narcolepsy Type 2, Narcolepsy Type 2 (NT2)

Studies at this site

• A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions — Recruiting now
• Study of SDX in Patients With Idiopathic Hypersomnia (IH) — Completed
• A Trial of Centanafadine Long-term Safety in Children and Adolescents With Attention-deficit/Hyperactivity Disorder. — Completed
• A Switch Study From High-Sodium Oxybate to Xywav to Evaluate Changes in Blood Pressure in Participants With Narcolepsy — Completed
• Solriamfetol's Effect on Cognitive Health in Apnea Participants During a Randomized Placebo-controlled Study — Completed
• Parallel Arm Trial of AD109 and Placebo With Patients With OSA (LunAIRo) — Completed
• Parallel-Arm Study to Compare AD109 to Placebo With Patients With OSA (SynAIRgy Study) — Completed
• A Study to Learn About How Elinzanetant Works and How Safe it is in Women Having Sleep Disturbances Associated With Menopause — Completed
• A Study to Investigate the Effect of XYWAV on Sleepiness, Polysomnography, and Functional Outcomes in Participants With Idiopathic Hypersomnia or Narcolepsy — Completed
• Continuation Protocol for Obstructive Sleep Apnea (OSA) — Enrolling by invitation
• A Study to Evaluate Safety, and Efficacy of SUVN-G3031 (Samelisant) in Patients With Narcolepsy With and Without Cataplexy — Completed
• A Study of TAK-861 in Participants With Narcolepsy Type 2 — Completed
• A Study of TAK-861 in Participants With Narcolepsy Type 1 — Completed
• A Study of TAK-994 in Adults With Type 1 and Type 2 Narcolepsy — Stopped early
• A Phase 3 Study to Assess the Safety and Efficacy of Pitolisant in Adult Patients With Idiopathic Hypersomnia — Completed
• An Interventional Safety Switch Study (Segue Study) of XYWAV in Narcolepsy — Completed
• A Study of TAK-994 in Adults With Narcolepsy — Stopped early
• Safety, Tolerability and Efficacy Study of V117957 in Subjects With Insomnia Associated With Alcohol Cessation — Completed
• Crossover Trial of AD036 in Obstructive Sleep Apnea — Completed
• Trial of AD036 in Obstructive Sleep Apnea — Completed
• Parallel Arm Trial of AD109 and AD504 In Patients With OSA — Completed
• Once-Nightly Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy — Completed
• A Multicenter Study of the Efficacy and Safety of JZP-258 in the Treatment of Idiopathic Hypersomnia (IH) With an Open-label Safety Extension — Completed
• A Study to Evaluate Next-Dose Transition From Zolpidem to Lemborexant (LEM) for the Treatment of Insomnia — Completed